Correlation Between Connect Biopharma and Vigil Neuroscience

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Connect Biopharma and Vigil Neuroscience at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Connect Biopharma and Vigil Neuroscience into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Connect Biopharma Holdings and Vigil Neuroscience, you can compare the effects of market volatilities on Connect Biopharma and Vigil Neuroscience and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Connect Biopharma with a short position of Vigil Neuroscience. Check out your portfolio center. Please also check ongoing floating volatility patterns of Connect Biopharma and Vigil Neuroscience.

Diversification Opportunities for Connect Biopharma and Vigil Neuroscience

0.02
  Correlation Coefficient

Significant diversification

The 3 months correlation between Connect and Vigil is 0.02. Overlapping area represents the amount of risk that can be diversified away by holding Connect Biopharma Holdings and Vigil Neuroscience in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vigil Neuroscience and Connect Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Connect Biopharma Holdings are associated (or correlated) with Vigil Neuroscience. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vigil Neuroscience has no effect on the direction of Connect Biopharma i.e., Connect Biopharma and Vigil Neuroscience go up and down completely randomly.

Pair Corralation between Connect Biopharma and Vigil Neuroscience

Given the investment horizon of 90 days Connect Biopharma Holdings is expected to generate 1.22 times more return on investment than Vigil Neuroscience. However, Connect Biopharma is 1.22 times more volatile than Vigil Neuroscience. It trades about -0.17 of its potential returns per unit of risk. Vigil Neuroscience is currently generating about -0.23 per unit of risk. If you would invest  122.00  in Connect Biopharma Holdings on August 24, 2024 and sell it today you would lose (23.00) from holding Connect Biopharma Holdings or give up 18.85% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy95.65%
ValuesDaily Returns

Connect Biopharma Holdings  vs.  Vigil Neuroscience

 Performance 
       Timeline  
Connect Biopharma 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Connect Biopharma Holdings are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Connect Biopharma sustained solid returns over the last few months and may actually be approaching a breakup point.
Vigil Neuroscience 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Vigil Neuroscience has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest unfluctuating performance, the Stock's technical and fundamental indicators remain persistent and the latest mess on Wall Street may also be a sign of long-standing gains for the company institutional investors.

Connect Biopharma and Vigil Neuroscience Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Connect Biopharma and Vigil Neuroscience

The main advantage of trading using opposite Connect Biopharma and Vigil Neuroscience positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Connect Biopharma position performs unexpectedly, Vigil Neuroscience can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vigil Neuroscience will offset losses from the drop in Vigil Neuroscience's long position.
The idea behind Connect Biopharma Holdings and Vigil Neuroscience pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.

Other Complementary Tools

Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Stocks Directory
Find actively traded stocks across global markets
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency